Physician profile
Stanley E Kraus
NPI 1720086713
$9,747.24
in general payments reported to CMS, 2019-2025
52 companies · $1,894 in 2025
The $1,894 reported for 2025 was more than what 79% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,215 · 2020: $756 · 2021: $640 · 2022: $1,288 · 2023: $1,805 · 2024: $2,149 · 2025: $1,894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,456 · Education: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,456.47 |
| Education | $392.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,010.36 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $974.89 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $915.42 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $754.02 | 2023-2025 | Gemtesa, Orgovyx |
| Tolmar, INC. | $592.49 | 2023-2025 | Eligard, Jatenzo |
| Teleflex LLC | $570.14 | 2021-2024 | Urolift |
| Endo USA, INC. | $354.80 | 2024-2025 | Aveed, Xiaflex |
| Antares Pharma, INC. | $326.15 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Bayer Healthcare Pharmaceuticals INC. | $306.45 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $306.25 | 2019-2025 | Adstiladrin |
| Endo Pharmaceuticals INC. | $279.08 | 2019-2024 | Xiaflex, Aveed |
| Myriad Genetic Laboratories, INC. | $266.77 | 2020-2025 | Prolaris, Myrisk |
| Abbvie INC. | $241.65 | 2022-2025 | |
| Neotract INC. | $224.15 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $223.27 | 2019-2025 | Provenge |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $220.12 | 2019-2025 | Gentlecath, Cure Ultra Catheter, Cure Catheter |
| Amgen INC. | $181.70 | 2019-2024 | Prolia |
| Progenics Pharmaceuticals, INC. | $138.36 | 2021-2024 | Pylarify |
| Acerus Pharmaceuticals Corporation | $120.91 | 2020-2022 | |
| Tolmar Pharmaceuticals, INC. | $109.42 | 2019-2022 | |
| Coloplast Corp | $102.52 | 2019-2024 | |
| Immunitybio, INC. | $102.26 | 2024-2025 | |
| Edap Technomed INC | $102.00 | 2024 | |
| Urogen Pharma, INC. | $84.13 | 2022-2023 | Jelmyto |
| Procept Biorobotics Corporation | $83.71 | 2023-2025 | Aquabeam Robotic System |
| C. R. Bard, INC. & Subsidiaries | $78.26 | 2024-2025 | Bard Urinary Drainage Bag |
| Travere Therapeutics, INC. | $77.58 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $75.39 | 2019-2023 | Yonsa |
| Halozyme INC | $69.54 | 2023 | |
| Laborie Medical Technologies Corp. | $67.31 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Gilead Sciences, INC. | $64.11 | 2022 | |
| Rochester Medical Corporation | $63.94 | 2019-2022 | |
| Hollister Incorporated | $63.64 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $52.13 | 2020-2023 | Lynparza, Keytruda |
| Myovant Sciences INC. | $46.15 | 2021-2022 | |
| Accord Healthcare, INC. | $44.47 | 2024-2025 | |
| Palette Life Sciences, INC. | $44.38 | 2022 | |
| Urovant Sciences INC | $42.68 | 2022 | |
| Novartis Pharmaceuticals Corporation | $41.55 | 2022-2023 | |
| Abc Home Medical Supply, INC. | $40.97 | 2024-2025 | |
| Blue Earth Diagnostics | $39.09 | 2019-2020 | |
| Bioprotect Medical, INC. | $31.94 | 2024 | Bioprotect Balloon Implant System |
| Convatec INC. | $31.17 | 2025 | |
| Mission Pharmacal Company | $30.63 | 2022-2023 | Uribel |
| Verity Pharmaceuticals INC. | $23.04 | 2025 | Tlando |
| Valencia Technologies Corporation | $21.98 | 2025 | Ecoin Device Kit |
| Cook Medical LLC | $21.78 | 2024 | Resonance |
| Axonics, INC. | $20.80 | 2023 | Axonics, Bulkamid |
| Agiliti Surgical, INC. | $20.24 | 2024 | Koelis Trinity Fusion Biopsy System, Endocare Cryocare Cs System, Sonablate Hifu |
| Allergan, INC. | $17.50 | 2019 | |
| Boston Scientific Corporation | $14.04 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Kraus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.